Skip to main content

VivoSim Labs, INC.

VIVS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001497253

In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding VivoSim Labs, INC. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of VIVS: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders3634−2
Shares796.5K718.7K−77.8K (−9.8%)
Value$1.35M$894.3K−$451.7K (−33.6%)

New holders (1)

Institutions that held VivoSim Labs, INC. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to VIVS in Q3 2023
InstitutionSharesValue% of portfolio
Householder Group Estate & Retirement Specialist, LLC1$10.00%

Sold out (3)

Institutions that held VivoSim Labs, INC. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of VIVS in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Citadel Advisors LLC13,867$23.4K
Plante Moran Financial Advisors, LLC1,550$2.62K
Coppell Advisory Solutions LLC125$215